109 results
Page 3 of 6
6-K
EX-99.6
zk7g60katpwp5c4hte
8 Oct 13
Lorus Therapeutics Signs Research and License Option Agreement with Elanco
12:00am
6-K
EX-99.1
sh2cp b5qjduk
10 Apr 13
Lorus Therapeutics Announces Presentation of Biomarker Data
12:00am
20-F/A
EX-4.4
ndkwlq7scz54vw
11 Jan 13
Annual report (foreign) (amended)
12:00am
6-K
EX-99.1
zyxf1
4 Oct 12
Lorus Therapeutics to Present at BioContact 2012 in Quebec City
12:00am
6-K/A
EX-99.7
1pjnec
27 Sep 12
Animal Rights License Agreement
12:00am
6-K
EX-99.3
hpm28hsodn2qogd
10 Aug 12
Independent Auditors' Report of Registered Public Accounting Firm
12:00am
6-K
EX-99.2
khlzaahs13gmww5pw5
10 Aug 12
Independent Auditors' Report of Registered Public Accounting Firm
12:00am
6-K
EX-99.3
56qh1p l2r
29 Aug 11
Consolidated Financial Statements of
12:00am
6-K
EX-99.2
qswn30y36vkror5
29 Aug 11
Consolidated Financial Statements of
12:00am
6-K
EX-99.3
uhk1fu0i8o
2 Dec 10
Lorus Therapeutics Closes Private Placement
12:00am
20-F/A
1ey3e v1u
1 Dec 10
Annual report (foreign) (amended)
12:00am
6-K
EX-99.2
ozl1fx ia0c
31 Aug 10
Consolidated Financial Statements of
12:00am
6-K
EX-9.3
qe640asidnthapapb
31 Aug 10
Consolidated Financial Statements of
12:00am
F-1/A
0pmftzp8ulcmp54wtch
3 Jun 10
Registration statement (foreign) (amended)
12:00am
F-1
hf9l68qrk q70a87jq6
6 Apr 10
Registration statement (foreign)
12:00am